Yew Bio-Pharm Group, Inc.

YEWB · OTC
Analyze with AI
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Assets
Cash & Equivalents$564$742$522$860
Short-Term Investments$0$0$0$0
Receivables$218$7,693$17$31,957
Inventory$15$2,637$6,205$2,579
Other Curr. Assets$9,193$599$5,645$38
Total Curr. Assets$9,989$11,671$12,389$35,434
Property Plant & Equip (Net)$823$875$519$580
Goodwill$0$0$0$0
Intangibles$41,980$40,081$34,960$6,370
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,654$1,580$1,824$10,547
Total NC Assets$48,457$42,535$37,303$17,496
Other Assets$0$0$0$0
Total Assets$58,447$54,207$49,692$52,930
Liabilities
Payables$424$148$268$460
Short-Term Debt$9,045$8,594$5,759$6,100
Tax Payable$974$116$190$6
Deferred Revenue$1$50$21$6
Other Curr. Liab.$81$1,573$824$473
Total Curr. Liab.$10,525$10,481$7,062$7,399
LT Debt$292$351$0$0
Deferred Rev, NC$1,173$892$340$360
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$974$1,088$1,203$0
Total NC Liab.$2,439$2,332$1,543$360
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$12,964$12,813$8,605$7,758
Equity
Pref Stock$0$0$0$0
Common Stock$52$52$52$52
Retained Earnings$31,416$29,951$28,965$30,288
AOCI$608-$2,191$2,116$4,469
Other Equity$13,407$13,582$13,716$14,126
Total Equity$45,483$41,394$41,087$45,172
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$58,447$54,207$49,692$52,930
Net Debt$8,774$8,202$5,237$5,240